Editorials in 1997

Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genes

• D Jacoby
• C Fraefel
• XO Breakefield

Immuno gene therapy comes into its own

• M Sadelain
• L Luzzatto

Cystic fibrosis: gene therapy or preventive gene transfer?

• L Drittanti
• MV Masciovecchio
• M Vega

Bridging the ‘commercialisation gap’ in Europe

• PA Martin

Why are we doing so much cancer gene therapy? Disentangling the scientific basis from the origins of gene therapy

• PR Lowenstein

Why: Gene Therapy?

• AG Dalgleish

Gene therapy for Parkinson's disease: current knowledge and future perspective

• MM Mouradian
• TN Chase

The importance of epidermal stem cells in keratinocyte-mediated gene therapy

• Michele De Luca
• Graziella Pellegrini

Suicide genes and bystander killing: local and distant effects

• M Siraç Dilber
• CI Edvard Smith

Combined strategies for gene therapy of AIDS

• Giorgio Palù

Nitroreductase activation of DB1954 – an alternative ‘suicide’ gene system

• SM Bailey
• IR Hart

Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vector

• R Michael Linden
• Kenneth I Berns